BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
nitric oxide metabolic process
,
Pseudomonas infection
,
Adipose tissue
,
Biofuel
,
LEP
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tyrosine-protein kinase, non-receptor Jak1
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Basophil of peripheral blood
Spleen
Lymph nodes
T Lymphocyte (regulatory) of peripheral blood
T Lymphocyte (CD4+) of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Hyperglycemia
Disorder related to transplantation
Autoimmune disease
Cryptosporidiosis
Musculoskeletal fibromatosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Colistin
idebenone
Il6st protein, rat
Triamterene
pyridine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
prdm1a
Ppp1r15a
DEAF1
BCKDK
Ppp1r15a
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
OMIM - Autoimmune and Inflammatory Disorders
Breast milk fat globule from lactating women at different time points post delivery
Liver Pharmacology and Xenobiotic Response Repertoire
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
Multiple myeloma cells with WT, mutant or null p53 status treated with PRIMA-1Met
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Tyrosine-protein kinase, non-receptor Jak1
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia
PCM1-JAK2 in Therapy Related Neoplasms
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (…
Inflammatory Signal Inhibitors for COVID-19 (MATIS)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ